| Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories J Ezzelle, IR Rodriguez-Chavez, JM Darden, M Stirewalt, N Kunwar, ... Journal of pharmaceutical and biomedical analysis 46 (1), 18-29, 2008 | 199 | 2008 |
| Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine P Gilbert, M Wang, T Wrin, C Petropoulos, M Gurwith, F Sinangil, ... The Journal of infectious diseases 202 (4), 595-605, 2010 | 157 | 2010 |
| Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma RF Little, JM Pluda, KM Wyvill, IR Rodriguez-Chavez, G Tosato, ... Blood 107 (12), 4650-4657, 2006 | 140 | 2006 |
| A pilot study of cidofovir in patients with kaposi sarcoma RF Little, F Merced-Galindez, K Staskus, D Whitby, Y Aoki, R Humphrey, ... The Journal of infectious diseases 187 (1), 149-153, 2003 | 99 | 2003 |
| Evaluation and recommendations on good clinical laboratory practice guidelines for phase I–III clinical trials M Sarzotti-Kelsoe, J Cox, N Cleland, T Denny, J Hural, L Needham, ... PLoS medicine 6 (5), e1000067, 2009 | 71 | 2009 |
| Characterization of the antigenic, immunogenic, and pathogenic variation of infectious bursal disease virus due to propagation in different host systems (bursa, embryo, and … IR Rodriguez-Chavez, JK Rosenberger, SS Cloud Avian Pathology 31 (5), 473-483, 2002 | 57 | 2002 |
| Empowering clinical research in a decentralized world W De Brouwer, CJ Patel, AK Manrai, IR Rodriguez-Chavez, NR Shah NPJ Digital Medicine 4 (1), 102, 2021 | 54 | 2021 |
| Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity R Yarchoan, JM Pluda, KM Wyvill, K Aleman, IR Rodriguez-Chavez, ... Critical reviews in immunology 27 (5), 401, 2007 | 43 | 2007 |
| Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies S Khurana, J Needham, B Mathieson, IR Rodriguez-Chavez, ... Journal of virology 80 (5), 2092-2099, 2006 | 35 | 2006 |
| Verification, analytical validation and clinical validation (V3) of wearable dosimeters and light loggers M Spitschan, K Smolders, B Vandendriessche, B Bent, JP Bakker, ... Digital health 8, 20552076221144858, 2022 | 31 | 2022 |
| Current advances and challenges in HIV-1 vaccines IR Rodriguez-Chavez, M Allen, EL Hill, RL Sheets, M Pensiero, JA Bradac, ... Current HIV/AIDS Reports 3, 39-47, 2006 | 20 | 2006 |
| Rigorous and rapid evidence assessment in digital health with the evidence DEFINED framework J Silberman, P Wicks, S Patel, S Sarlati, S Park, IO Korolev, JR Carl, ... NPJ Digital Medicine 6 (1), 101, 2023 | 17 | 2023 |
| Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants O Penezina, NX Krueger, IR Rodriguez-Chavez, MP Busch, J Hural, ... Clinical and Vaccine Immunology 21 (3), 391-398, 2014 | 17 | 2014 |
| Recommendations for defining and reporting adherence measured by biometric monitoring technologies: systematic review IM Olaye, MP Belovsky, L Bataille, R Cheng, A Ciger, KL Fortuna, ... Journal of Medical Internet Research 24 (4), e33537, 2022 | 15 | 2022 |
| HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection S Khurana, PJ Norris, MP Busch, BF Haynes, S Park, P Sasono, ... Journal of clinical microbiology 48 (1), 281-285, 2010 | 12 | 2010 |
| Considerations for analyzing and interpreting data from biometric monitoring technologies in clinical trials B Ratitch, IR Rodriguez-Chavez, A Dabral, A Fontanari, J Vega, F Onorati, ... Digital Biomarkers 6 (3), 83-97, 2022 | 7 | 2022 |
| New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants O Penezina, D Clapham, J Collins, V Kovalenko, N Krueger, ... Retrovirology 9, 1-1, 2012 | 3 | 2012 |
| PART IV. Cytokine and Hormone Immunotherapy Treatment of AIDS-Related Kaposi's Sarcoma with Interleukin-12: Rationale and Preliminary Evidence of Clinical Activity R Yarchoan, JM Pluda, KM Wyvill, K Aleman, IR Rodriguez-Chavez, ... Critical Reviews™ in Immunology 27 (5), 2007 | 3 | 2007 |
| P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials M Sarzotti-Kelsoe, J Cox, N Cleland, T Denny, J Hural, L Needham, ... Retrovirology 6, 1-1, 2009 | 2 | 2009 |
| Guidelines and Guidance-Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I-III Clinical Trials M Sarzotti-Kelsoe, J Cox, N Cleland, T Denny, J Hural, L Needham, ... PLoS Medicine 6 (5), 495, 2009 | 1 | 2009 |
